NCT04693988

Brief Summary

Outpatient cardiac rehabilitation (CR) is an exercise-based lifestyle program for patients who have experienced a myocardial infarction, systolic heart failure, percutaneous revascularization or cardiac surgery. CR plays a key role in secondary prevention, which is the prevention of subsequent cardiac events. CR has been shown to reduce both cardiovascular mortality and one year hospital readmissions as well as improve quality of life, exercise capacity, and physical function. Although the benefits have been clearly established for cardiac patients, women are much less likely to attend CR than men. Based upon our own preliminary data (and the medical literature), attendance at CR is determined by factors that vary in their importance between men and women. These findings demonstrate that older age and poor social support are particular barriers to CR participation in women. This information can guide efforts to increase CR participation and adherence in women, areas which have received little study. Case management (CM) has been effective at reducing cardiovascular risk and reducing hospitalizations amongst cardiac patients. Further, CM has been effective at promoting attendance in a variety of health related programs (for example, diabetes treatment or cocaine dependence treatment). The primary aim in this randomized controlled trial is to examine the efficacy of early CM to promote participation and adherence in CR. The CM model can identify individualized determinants of health and social needs to identify potential barriers which may hinder CR enrollment. Additionally, the case manager will conduct a home visit and provide individual counseling to address lifestyle changes including physical activity. Thus, a component of CR and physical activity can be still be delivered for those unable to attend CR. The concept of CM to improve CR participation and adherence has not been specifically tested in women, a vulnerable patient population. This intervention, therefore, has the potential to increase utilization of CR and significantly improve health outcomes in female cardiac patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
113

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 31, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

January 18, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

December 5, 2023

Status Verified

December 1, 2023

Enrollment Period

2.9 years

First QC Date

December 31, 2020

Last Update Submit

December 4, 2023

Conditions

Keywords

Secondary Prevention, Women's cardiovascular disease, case management

Outcome Measures

Primary Outcomes (2)

  • Cardiac Rehabilitation Participation

    Attendance of at least 1 session

    within 4 months of the intake assessment

  • Cardiac Rehabilitation Adherence

    Number of cardiac rehabilitation sessions completed out of a possible 36

    within 4 months of the intake assessment

Secondary Outcomes (5)

  • Changes in Physical Activity

    within 4 months of the intake assessment

  • Changes in Quality of Life

    within 4 months of the intake assessment

  • Changes in Self Reported Physical Function

    within 4 months of the intake assessment

  • Changes in Depression

    within 4 months of the intake assessment

  • Changes in Anxiety

    within 4 months of the intake assessment

Other Outcomes (6)

  • Maintenance of Physical Activity following Intervention

    From completion of intervention (4 months) to follow up (one year)

  • Maintenance of Quality of Life following Intervention

    From completion of intervention (4 months) to follow up (one year)

  • Maintenance of Self Reported Physical Function following Intervention

    From completion of intervention (4 months) to follow up (one year)

  • +3 more other outcomes

Study Arms (2)

Case management

EXPERIMENTAL

Patient receives case management while in hospital.

Behavioral: Case Management

Usual Care

NO INTERVENTION

This control condition does not receive intervention of case management

Interventions

Case ManagementBEHAVIORAL

a case manager is available by phone to assist patient with attending cardiac rehabilitation sessions as well as provide advice about cardiac symptoms and behavioral life style changes

Case management

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A cardiac rehabilitation qualifying condition including: A recent myocardial infarction or coronary revascularization or heart valve replacement or repair, stable angina, or congestive heart failure (ejection fraction \<35%)
  • Lives in and plans to remain in the greater Burlington, Vermont area for the next year.

You may not qualify if:

  • Severe dementia
  • Advanced cancer, advanced frailty, or other longevity-limiting systemic disease
  • Severe life threatening ventricular arrhythmias unless adequately controlled (e.g. intracardiac defibrillator)
  • Exercise-limiting non-cardiac disease such as severe arthritis, past stroke leading to paralysis
  • Participation in cardiac rehab within the past year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vermont Medical Center

Burlington, Vermont, 05405, United States

Location

MeSH Terms

Interventions

Case Management

Intervention Hierarchy (Ancestors)

Patient Care PlanningComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

December 31, 2020

First Posted

January 5, 2021

Study Start

January 18, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2024

Last Updated

December 5, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations